RAJKUMAR VENKATRAMANI to Drug Industry
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Drug Industry.
Connection Strength
0.048
-
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration. Eur J Cancer. 2021 11; 157:198-213.
Score: 0.048